The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2016

Filed:

May. 09, 2014
Applicants:

Upkar Bhardwaj, Coram, NY (US);

Ann Reese Comfort, New York, NY (US);

Ping LI, Basking Ridge, NJ (US);

Shoufeng LI, Basking Ridge, NJ (US);

Alexey Makarov, Montclair, NJ (US);

Mangesh Sadashiv Bordawekar, Parsippany, NJ (US);

Inventors:

Upkar Bhardwaj, Coram, NY (US);

Ann Reese Comfort, New York, NY (US);

Ping Li, Basking Ridge, NJ (US);

Shoufeng Li, Basking Ridge, NJ (US);

Alexey Makarov, Montclair, NJ (US);

Mangesh Sadashiv Bordawekar, Parsippany, NJ (US);

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 9/2866 (2013.01); A61K 9/2893 (2013.01);
Abstract

A solid dosage form of nilotinib is disclosed that comprises: (i) a core comprising 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide or a pharmaceutically acceptable salt thereof and excipients; and (ii) at least one polymer, said polymer coating said core, wherein disintegration of said solid dosage form is delayed.


Find Patent Forward Citations

Loading…